A bioequivalence study of two brands of sumatriptan tablets

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 8, 1996, Pages 589-598

  Usha Rani, P ^a   Naidu, M U R ^a   Ramesh Kumar, T ^a   Shobha, J C ^a   Vijay, T ^a   Ravi Sekhar, K ^a   Chandra Sekhar, E ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN; SUMATRIPTAN SUCCINATE; SUMINAT; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; VOLUNTEER;

EID: 9444254175     PISSN: 0011393x     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80009-9     Document Type: Article

References (12)

1. Sumatriptan—a review of its pharmacodynamic and pharmaco-kinetic properties and therapeutic efficacy in the acute treatment of migraine and cluster headache
2. Sumatriptan (succinate)
3. Effects of prophylactic migraine medications on the pharmacokinetic and pharmacodynamic profiles of sumatriptan
4. The clinical pharmacology of sumatriptan
5. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan
6. Early studies with the novel 5-HT like agonist GR 43175 in healthy volunteers
7. Disposition of sumatriptan in laboratory animals and humans
8. Phase I study of sumatriptan injection (the 2nd report): Single and multiple subcutaneous dose study in Japanese healthy subjects
9. Phase I study of sumatriptan tablet (the 1st report): Single and multiple oral dose study in Japanese subjects
10. Oral sumatriptan pharmacokinetics in the migrainous state
11. Phase I clinical study of antimigraine drug sumatriptan (SN-308) single and repeated subcutaneous administration